Comrad

Comrad

Growth Stage

Socks Reinvented: Premium compression socks designed for comfort and performance

Socks Reinvented: Premium compression socks designed for comfort and performance

Overview

Raised this Round: Raised: $82,247

Total Commitments ($USD)

Platform

Republic

Start Date

08/24/2022

Close Date

12/26/2022

Min. Goal
$25,000
Max. Goal
$1,070,000
Min. Investment

$250

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$25,000,000

Discount

0%

Year Founded

2015

Industry

Apparel & Fashion

Tech Sector

HealthTech

Distribution Model

B2C

Margin

High

Capital Intensity

Low

Location

Claymont, Delaware

Business Type

Growth

Comrad, with a valuation of $25 million, is raising funds on Republic. The company makes premium compression socks designed for comfort and performance. The socks of Comrad soothe and energize legs and feet while people are standing, sitting, traveling, exercising, or working out. The socks are designed with specific ranges of compression that increase circulation and provide wellness benefits. Comrad is on a $10 million revenue run-rate as of Q2 2022 and has reported a 223% annual revenue growth since its launch. Andrew Ferenci founded Comrad in October 2015. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1,070,000. The campaign proceeds will be used to launch new products.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$4,297,364

$3,418,223

COGS

$946,144

$729,922

Tax

$0

$0

 

 

Net Income

$-1,644,286

$-1,071,971

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$414,282

$792,877

Accounts Receivable

$0

$0

Total Assets

$1,325,748

$1,311,437

Short-Term Debt

$3,878,132

$3,861,071

Long-Term Debt

$649,533

$214,040

Total Liabilities

$4,527,665

$4,075,111

Financials as of: 08/24/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Analyst Report Analyst Report Methodology Article

Compression socks were originally designed for medial use — to improve circulation or help with musculoskeletal ailments like plantar fasciitis. But thanks to the range of health benefits they offer, compression socks are becoming increasingly popular. You don’t have to be a nurse or have aches in your feet to enjoy improved blood flow, decreased swelling, and even lymphatic drainage.

Those benefits were exactly what Andrew Ferenci needed. He had a job that required him to travel regularly. The frequent plane rides were causing swelling and pain in his feet. He wanted a solution that didn’t scream “medical device,” something he could wear with his regular clothes that wouldn’t draw attention or distract from his work. Thus, Comrad was born.

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Comrad on Republic 2022
Platform: Republic
Security Type: SAFE
Valuation: $25,000,000

Follow company

Follow Comrad on Republic 2022

Buy Comrad's Deal Report

Warning: according to the close date for this deal, Comrad may no longer be accepting investments.

Comrad Deal Report

Get KingsCrowd’s comprehensive report on Comrad including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Comrad is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise
  • Our deep-dive analyst report reviewing the deal's investment potential and bullish vs. bearish outlook

Buy the Comrad deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge